NYSE: RDYDr Reddys Laboratories Revenue
Dr Reddys Laboratories revenue was $3.79B for the trailing 12 months ending Mar 31, 2025, with -1.1% growth year over year. For the last reported fiscal year 2025 ending Mar 31, 2025, RDY annual revenue was $3.8B, with 13.7% growth year-over-year.
RDY past revenue growth
How has RDY's revenue growth performed historically?
Company
13.73%
Industry
9.32%
Market
34.56%
RDY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RDY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RDY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
RDY revenue history
Current Revenue
$3.8B
Current Earnings
$661.6M
Current Profit Margin
17.4%
RDY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when RDY announces revenue.
RDY Revenue History By Year
| RDY Yearly Revenue | RDY Revenue | RDY Change | RDY Revenue Growth |
|---|---|---|---|
| 2025-03-31 | $3.81B | $459.91M | +13.73% |
| 2024-03-31 | $3.35B | $358.07M | +11.97% |
| 2023-03-31 | $2.99B | $177.70M | +6.32% |
| 2022-03-31 | $2.81B | $228.76M | +8.85% |
| 2021-03-31 | $2.58B | $269.12M | +11.62% |
| 2020-03-31 | $2.32B | $92.37M | +4.15% |
| 2019-03-31 | $2.22B | $41.59M | +1.91% |
| 2018-03-31 | $2.18B | $13.23M | +0.61% |
| 2017-03-31 | $2.17B | -$165.42M | -7.09% |
| 2016-03-31 | $2.33B | -$33.74M | -1.42% |
| 2015-03-31 | $2.37B | $159.81M | +7.24% |
| 2014-03-31 | $2.21B | $67.37M | +3.15% |
| 2013-03-31 | $2.14B | $232.67M | +12.20% |
| 2012-03-31 | $1.91B | $231.72M | +13.83% |
| 2011-03-31 | $1.68B | $111.28M | +7.11% |
| 2010-03-31 | $1.56B | $196.96M | +14.40% |
| 2009-03-31 | $1.37B | $118.16M | +9.46% |
| 2008-03-31 | $1.25B | -$252.04M | -16.78% |
| 2007-03-31 | $1.50B | $956.84M | +175.61% |
| 2006-03-31 | $544.85M | $97.83M | +21.89% |
| 2005-03-31 | $447.02M | -$16.09M | -3.47% |
| 2004-03-31 | $463.11M | $83.72M | +22.07% |
| 2003-03-31 | $379.39M | $38.58M | +11.32% |
| 2002-03-31 | $340.80M | $104.67M | +44.33% |
| 2001-03-31 | $236.13M | N/A | N/A |
Dr Reddys Laboratories Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.